Brepte for the pain of the European pharmaceutical industry as Trump's tariff threat looms
Insulin, cardiac treatments and antibiotics have flowed freely on many boundaries for decades, free from the rates in an attempt to make medicine accessible. But this could soon change.For months, President Trump has promised to impose higher rates to pharmaceutical products as part of his plan to rearrange the global trading system and report the key manufacturing industries in the United States. This month, he said that the pharmaceutical rates could arrive in the "not too distant future".If they did, the move would have serious - and wildly uncertain consequences - for drugs made in the European Union.Pharmaceutical products and chemicals are export n. 1 of the blockage in America. Among these are the successful ozemics of weight loss, cancer treatments, cardiovascular drugs and flu vac...